Sign In To Continue
You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
On May 18, 2021, China’s Center for Drug Evaluation (CDE) under the National Medical Products Administration (NMPA) announced the public testing phase of its patent linkage registration platform. This system, designed to facilitate early settlement of drug patent disputes, is open for testing through May 31, 2021. The…
Share This Article
Ready-to-post copy includes the article link.
China’s National Medical Products Administration Launches Public Test for Drug Patent Linkage Registration Platform On May 18, 2021, China’s Center for Drug Evaluation (CDE) under the National Medical Products Administration (NMPA) announced the public testing phase of its patent linkage registration platform. This system, designed t... Read the full IIPLA article: https://iipla.org/news/china-s-national-medical-products-administration-launches-public-test-for-drug-patent-linkage-registration-platform